Ublituximab: a new anti-CD20 agent for multiple sclerosis
Jiwon Oh, Amit Bar‐Or
Topics & Concepts
OcrelizumabOfatumumabTeriflunomideMedicineMultiple sclerosisWeb of scienceDaclizumabRituximabDermatologyInternal medicineFingolimodMonoclonal antibodyImmunologyAntibodyLymphomaMeta-analysisMultiple Sclerosis Research StudiesImmunotherapy and Immune ResponsesPeripheral Neuropathies and Disorders